SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-19-000255
Filing Date
2019-01-11
Accepted
2019-01-11 09:51:38
Documents
1
Period of Report
2019-01-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 2251
  Complete submission text file 0001562180-19-000255.txt   3682
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Issuer) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROGENICS PHARMACEUTICALS, INC. 1 WORLD TRADE CENTER, 47TH FL, SUITE J NEW YORK NY 10007
Business Address
Das Asha (Reporting) CIK: 0001701647 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23143 | Film No.: 19521551